Evidence map›Paper›PMID 42006404›Full record

ArticleJournal of bone oncology2026

Nationwide epidemiologic study of osteochondroma in Japan: Analysis of 4843 cases from the bone and soft tissue tumor registry.

Kazu Matsumoto, Kazuki Sohmiya, Daisuke Kobayashi, Akira Ogose, Kota Watanabe, Akihiko Takeuchi, Akira Kido, Michio Ozeki, Hiroshi Furukawa, Akira Kawai and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of bone oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Kazu MatsumotoDepartment of Orthopedic Surgery, Gifu Seiryu Hospital, Gifu, Japan.
Kazuki SohmiyaDepartment of Orthopedic Surgery, Gifu Seiryu Hospital, Gifu, Japan.
Daisuke KobayashiDepartment of Orthopaedic Surgery, Kobe Children's Hospital, Kobe, Japan.
Akira OgoseDepartment of Orthopedics, Uonuma Kikan Hospital, Minamiuonuma, Japan.
Kota WatanabeDepartment of Orthopaedic Surgery, Keio University School of Medicine, Tokyo, Japan.
Akihiko TakeuchiTakeuchi Orthopaedic Clinic, Shiga, Japan.
Akira KidoDepartment of Rehabilitation Medicine, Nara Medical University, Nara, Japan.
Michio OzekiDepartment of Pediatrics, Graduate School of Medicine, Gifu University, Gifu, Japan.
Hiroshi FurukawaDepartment of Plastic and Reconstructive Surgery, Aichi Medical University, Nagakute, Japan.
Akira KawaiDepartment of Musculoskeletal Oncology and Rehabilitation Medicine, National Cancer Center Hospital, Tokyo, Japan.
Yoshihiro NishidaDepartment of Rehabilitation Medicine, Nagoya University Hospital, Nagoya, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteochondroma is the most common benign bone tumor; however, large-scale epidemiologic data remain limited, particularly in Asian populations. This nationwide registry-based study aimed to clarify the epidemiology and clinical characteristics of osteochondroma in Japan. Patients diagnosed with osteochondroma between 2006 and 2019 were identified from the Bone and Soft Tissue Tumor (BSTT) Registry of the Japanese Orthopaedic Association. Demographics, tumor location, subtype (solitary osteochondroma [SO] vs. multiple osteochondroma [MO]), and surgical history were analyzed, and comparisons between SO and MO were performed using χ

Indexed as

Bone tumor registryEpidemiologyHereditary multiple exostosesLong bone involvementMultiple osteochondromasOsteochondromaSolitary osteochondroma

Identifiers

PMID42006404
PMCPMC13091020

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.